CAS 144750-42-5
:Composto Relacionado A de Clopidogrel USP
Descrição:
Composto Relacionado A de Clopidogrel USP, com o número CAS 144750-42-5, é uma substância química que está estruturalmente relacionada ao medicamento antiplaquetário clopidogrel. É caracterizada principalmente por seu papel como impureza ou produto de degradação na síntese do clopidogrel. Este composto é tipicamente identificado através de técnicas analíticas como cromatografia líquida de alta eficiência (HPLC) e espectrometria de massas. Sua estrutura molecular apresenta grupos funcionais específicos que contribuem ao seu comportamento químico e estabilidade. O clopidogrel em si é um pró-fármaco que requer ativação metabólica para exercer seus efeitos farmacológicos, e compostos relacionados como o Composto A podem apresentar diferentes graus de atividade biológica ou toxicidade. A presença de tais compostos relacionados é importante para o controle de qualidade nas formulações farmacêuticas, pois podem influenciar a eficácia e segurança do produto final. Diretrizes regulatórias frequentemente ditam os limites aceitáveis para essas impurezas para garantir a segurança do paciente e a eficácia do medicamento.
Fórmula:C15H14ClNO2S·ClH
InChI:InChI=1S/C15H14ClNO2S.ClH/c16-12-4-2-1-3-11(12)14(15(18)19)17-7-5-13-10(9-17)6-8-20-13;/h1-4,6,8,14H,5,7,9H2,(H,18,19);1H/t14-;/m0./s1
Chave InChI:InChIKey=FOKSIOUPGDBSLC-UQKRIMTDSA-N
SMILES:[C@H](C(O)=O)(N1CC2=C(CC1)SC=C2)C3=C(Cl)C=CC=C3.Cl
Sinónimos:- (+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride
- (2S)-(2-Chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride (1:1)
- (S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride
- (αS)-α-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid hydrochloride (1:1)
- Clopidogrel Related Compound A
- Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, hydrochloride (1:1), (αS)-
- Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, hydrochloride, (αS)-
- Clopidogrel Related Compound A (20 mg) ((S)-(ochlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-aceticv acid, hydrochloride)
- Clopidogrel Impurity 1 HCl(Clopidogrel EP Impurity A HCl)
- CLOPIDOGREL RELATED COMPOUND A (20 MG) ((S)-(O-CHLOROPHENYL)-6,7-DIHYDROTHIENO[3,2-C]PYRI-DINE-5(4H)-ACETIC ACID, HYDROCHLORIDE)
- Clopidogrel carboxylic acid Impurity
- Clopidogrel USP Related CoMpound A
- Clopidogrel Related Compound A as Hydrochloride
- Clopidogrel Impurity 2/Clopidogrel EP Impurity A HCl/(S)-Clopidogrel Acid Hydrochloride/(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno-[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride
- Clopidogrel USP Related Compound A as Hydrochloride
- alpha-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid hydrochloride
- Clopidogrel Hydrogen Sulfate EP Impurity A as Hydrochloride
- (+)-(S)-(o-Chlorophenyl)-6,7-dihydrothieno3,2-cpyridine-5(4H)-acetic acid hydrochloride
- Clopidogrel USP RC A
- Clopidogrel Hydrogen Sulfate Impurity A as Hydrochloride
- (S)-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid hydrochloride
- (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride? (Clopidogrel Impurity)
- Clopidogrel acid hydrochloride
- Clopidogrel EP Impurity A HCl
- Clopidogrel EP IMpurity-A
- Clopidogrel Related Compound A ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-ace (1140586)
- Clopidogrel Carboxylic Acid Hydrochloride Salt
- Clopidogrel Impurity A(EP)
- Clopidogrel Related Compound A (H0M124)
- Clopidogrel EP impurity-A (USP RC A)
- Clopidogrel Carboxylic Acid Hydrochloride
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
10 produtos.
Clopidogrel Related Compound A ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H14ClNO2S·HClCor e Forma:Off-White PowderPeso molecular:307.04338Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, hydrochloride (1:1), (αS)-
CAS:Fórmula:C15H15Cl2NO2SPureza:95%Cor e Forma:SolidPeso molecular:344.2561(S)-2-(2-Chlorophenyl)-2-(6,7-Dihydrothieno[3,2-c]Pyridin-5(4H)-Yl)Acetic Acid Hydrochloride
CAS:(S)-2-(2-Chlorophenyl)-2-(6,7-Dihydrothieno[3,2-c]Pyridin-5(4H)-Yl)Acetic Acid HydrochloridePureza:98%Peso molecular:344.26g/mol(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride
CAS:Pureza:95.0%Peso molecular:344.25Clopidogrel Carboxylic Acid hydrochloride
CAS:Clopidogrel Carboxylic Acid hydrochloride (SR 26334) is a major inactive metabolite of clopidogrel, commonly used as a reference standard for metabolic analysi.Fórmula:C15H15Cl2NO2SPureza:99.32%Cor e Forma:SolidPeso molecular:344.26Clopidogrel Carboxylic Acid Hydrochloride
CAS:Produto Controlado<p>Impurity Clopidogrel EP Impurity A; Clopidogrel Impurity A; Clopidogrel USP A<br>Stability Hygroscopic<br>Applications Clopidogrel Carboxylic Acid Hydrochloride (Clopidogrel EP Impurity A; Clopidogrel Impurity A; Clopidogrel USP A) is the hydrochloride salt of a metabolite of the drug Clopidogrel.<br>References Savi, P., et al.: Biochem. Pharmacol., 44, 527 (1992), Pereillo, J., et al.: Drug Metab. Dispos., 30, 1288 (2002), Ksycinska, H., et al.: J. Pharm. Biomed. Anal., 41, 533 (2006), Farid, N., et al.: Clin. Pharmacol. Ther., 81, 735 (2007),<br></p>Fórmula:C15H14ClNO2S·ClHCor e Forma:Light YellowPeso molecular:344.26(R)- Clopidogrel Carboxylic Acid Hydrochloride
CAS:Produto ControladoFórmula:C15H14ClNO2S·HClCor e Forma:NeatPeso molecular:344.26Clopidogrel Impurity A
CAS:<p>Clopidogrel Impurity A is a medicine that is used for the prevention of heart attacks, strokes, and blood clots in people with an increased risk of these events. It is not intended to be used for immediate relief from sudden symptoms. Clopidogrel Impurity A is a substance that may be found in some preparations of clopidogrel. The presence of this substance can be detected by liquid chromatography-mass spectrometry (LC-MS/MS) methods. The structural analysis of this substance was determined using enantiomeric resolution and chromatographic methods. This impurity has been shown to have no effect on the bioavailability of the parent drug, clopidogrel, when given orally to Sprague-Dawley rats.</p>Fórmula:C15H15Cl2NO2SPureza:Min. 95%Peso molecular:344.26 g/mol









